Skip to content
Home/Companies/Biotech/Cytospire Therapeutics
CT

Cytospire Therapeutics

Biotech·UK·Active·0yr hold

Cytospire Therapeutics is a biotech company, headquartered in UK.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Cytospire Therapeutics?

Cytospire Therapeutics is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2026. Across its history, Cytospire Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-21

4Bio Partners
Most recent investor
4Bio Partners
4BIO Ventures III · 2022 · Life Sciences VC
3 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

3 ownership periods

Active
Co-held by LifeArc, Abingworth and 4Bio Partners since 2023.
LifeArc
LifeArcActive
2023 · present · LifeArc Ventures · 1992 · Life Sciences VC
MOIC
–
Abingworth
AbingworthActive
2026 · present · Abingworth Bioventures 8 · 2021 · Life Sciences VC
MOIC
–
4Bio Partners
4Bio PartnersActive
2026 · present · 4BIO Ventures III · 2022 · Life Sciences VC
MOIC
–

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Actithera
Active
BiotechSwitzerland· 2025
Hornet Therapeutics
Active
BiotechUK· 2024
March Biosciences
Active
BiotechUS· 2024
Ascend Advanced Therapies
Active
BiotechUK· 2023
Trogenix
Active
BiotechUK· 2023
ViaNautis Bio
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings